BioPhorum Unites Regulators, Big Pharma and CDMOs to Accelerate Synthetic Molecule Innovation
LONDON – BioPhorum has announced the formation of the Synthetic Molecule Process Innovation Phorum, uniting an ecosystem of 20 leading organizations to urgently address the rapidly accelerating pace of innovation in the small molecule sector.
This new initiative represents a significant portion of the small molecule supply chain, bringing together global pharmaceutical companies, including AstraZeneca, GSK, Merck, Merck & Co Inc. Rahway, N.J. USA, Roche, Takeda, and Eli Lilly, alongside specialist contract development and manufacturing organizations (CDMOs), technology partners and regulatory authorities.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the British Pharmacopoeia, and the US Pharmacopeia are actively participating to help accelerate harmonized industry change. A core purpose of this new Phorum is to serve as the critical interface between the industry and these regulators to create global acceptance of change for new ways of working.
The synthetic molecule sector is experiencing a powerful renaissance, driven by breakthroughs in precision oncology, neurology, and next-generation oral therapies. As pipelines shift from niche, high-potency compounds to high-volume global treatments, the industry faces an urgent need to adopt advanced, agile manufacturing technologies. Accelerating this innovation requires seamless collaboration across the ecosystem to ensure facilities can efficiently scale up, scale out, and secure global supply chains for the next generation of patient care.
“As pipelines fill with complex small molecules, from next‑generation obesity treatments to breakthrough therapies in oncology and immunology, the question is no longer whether science can deliver, but whether manufacturing can keep up,” said Andrea Johnston, Senior Phorum Director at BioPhorum.
“By bringing global pharma and specialist CDMOs around one table, the BioPhorum Synthetic Molecule Process Innovation is designed to turn market momentum into robust, efficient, and sustainable ways of making these products at scale.”
For further information about the BioPhorum Synthetic Molecule Process Innovation collaboration, please visit the BioPhorum website here: https://www.biophorum.com/phorum/biophorum-synthetic-molecule-process-innovation/
Total Page Views: 14
